Fluoropharma Medical Stock Buy Hold or Sell Recommendation
| FPMI Stock | USD 0.0001 0.00 0.00% |
Given the investment horizon of 90 days and complete risk avoidance on your part, our recommendation regarding Fluoropharma Medical is 'Strong Sell'. The recommendation algorithm takes into account all of Fluoropharma Medical's available fundamental, technical, and predictive indicators you will find on this site.
Check out Fluoropharma Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Fluoropharma and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Fluoropharma Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Fluoropharma |
Execute Fluoropharma Medical Buy or Sell Advice
The Fluoropharma recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Fluoropharma Medical. Macroaxis does not own or have any residual interests in Fluoropharma Medical or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Fluoropharma Medical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Fluoropharma Medical Trading Alerts and Improvement Suggestions
| Fluoropharma Medical generated a negative expected return over the last 90 days | |
| Fluoropharma Medical has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (2.05 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Fluoropharma Medical currently holds about 24.72 K in cash with (880.12 K) of positive cash flow from operations. |
Fluoropharma Medical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Fluoropharma Medical or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Fluoropharma Medical's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Fluoropharma pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Fluoropharma Medical Volatility Alert
At this time Fluoropharma Medical exhibits very low volatility. Fluoropharma Medical appears to be a penny stock. Although Fluoropharma Medical may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Fluoropharma Medical or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Fluoropharma instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Fluoropharma Medical Fundamentals Vs Peers
Comparing Fluoropharma Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Fluoropharma Medical's direct or indirect competition across all of the common fundamentals between Fluoropharma Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Fluoropharma Medical or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Fluoropharma Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Fluoropharma Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Fluoropharma Medical to competition |
| Fundamentals | Fluoropharma Medical | Peer Average |
| Return On Asset | -2.35 | -0.14 |
| Current Valuation | 9.23 M | 16.62 B |
| Shares Outstanding | 34.26 M | 571.82 M |
| Shares Owned By Institutions | 0.34 % | 39.21 % |
| Price To Earning | (0.39) X | 28.72 X |
| Price To Book | 17.76 X | 9.51 X |
| EBITDA | (2.16 M) | 3.9 B |
| Net Income | (2.05 M) | 570.98 M |
| Cash And Equivalents | 24.72 K | 2.7 B |
| Total Debt | 5.82 M | 5.32 B |
| Debt To Equity | 0.07 % | 48.70 % |
| Book Value Per Share | (0.30) X | 1.93 K |
| Cash Flow From Operations | (880.12 K) | 971.22 M |
| Earnings Per Share | (0.08) X | 3.12 X |
| Target Price | 2.5 | |
| Number Of Employees | 4 | 18.84 K |
| Beta | -59.92 | -0.15 |
| Market Capitalization | 3.43 M | 19.03 B |
| Total Asset | 334.76 K | 29.47 B |
| Retained Earnings | (34.16 M) | 9.33 B |
| Working Capital | (10.23 M) | 1.48 B |
| Current Asset | 89 K | 9.34 B |
| Current Liabilities | 10.32 M | 7.9 B |
| Net Asset | 334.76 K |
Fluoropharma Medical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Fluoropharma . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
About Fluoropharma Medical Buy or Sell Advice
When is the right time to buy or sell Fluoropharma Medical? Buying financial instruments such as Fluoropharma Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Fluoropharma Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Printing and Publishing Thematic Idea Now
Printing and Publishing
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Printing and Publishing theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Printing and Publishing Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Fluoropharma Pink Sheet
Fluoropharma Medical financial ratios help investors to determine whether Fluoropharma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fluoropharma with respect to the benefits of owning Fluoropharma Medical security.